Correction to: pexidartinib: first approval
YN Lamb - Drugs, 2020 - Springer
Correction to: Pexidartinib: First Approval | Drugs Skip to main content SpringerLink Account
Menu Find a journal Publish with us Search Cart 1.Home 2.Drugs 3.Article Correction to …
Menu Find a journal Publish with us Search Cart 1.Home 2.Drugs 3.Article Correction to …
Correction to: Pexidartinib: First Approval
YN Lamb - Drugs, 2020 - search.proquest.com
The article Pexidartinib: First Approval, written by Yvette N. Lamb was originally published
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …
Correction to: Pexidartinib: First Approval.
YN Lamb - Drugs, 2020 - search.ebscohost.com
The article Pexidartinib: First Approval, written by Yvette N. Lamb was originally published
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …
Correction to: Pexidartinib: First Approval
YN Lamb - Drugs, 2020 - ncbi.nlm.nih.gov
The article Pexidartinib: First Approval, written by Yvette N. Lamb was originally published
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …
Correction to: Pexidartinib: First Approval.
YN Lamb - Drugs, 2020 - europepmc.org
The article Pexidartinib: First Approval, written by Yvette N. Lamb was originally published
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …
Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested …